Raw Talks With VK: Why Hyderabad's Genome Valley Dominates Global Generic Drug Formulations
Industrialist Dr. Krishna Prasad joins Vamshi Kurapati to break down how Telangana built Genome Valley, conquered US generic markets, and scaled high-volume active pharmaceutical ingredient chemistry.
While Bangalore is recognized as India's software capital, Hyderabad serves as the indispensable pharmacy to the world. On Raw Talks With VK, pharma veteran Dr. Krishna Prasad explains how the Deccan plateau became the nexus of global life sciences.
The Chemistry of Global Dominance
Prasad reveals the sheer scale of Indian bulk drug manufacturing:
"One in every three generic pills swallowed in America and Europe traces its chemical origin back to factories situated in and around Hyderabad."
From paracetamol to critical oncology active pharmaceutical ingredients (APIs), the city's manufacturing ecosystem provides essential low-cost medications that keep Western healthcare systems solvent.
The Genome Valley Advantage
Decades of deliberate state industrial policy created Genome Valley, an integrated cluster housing over two hundred life sciences corporations. Shared testing laboratories, rapid environmental clearance pipelines, and proximity to Indian Institute of Chemical Technology (IICT) created unmatched operational efficiencies.
Surviving US FDA Regulatory Audits
Operating in regulated Western markets requires passing rigorous, unannounced FDA plant inspections. Prasad emphasizes that modern Indian pharma has evolved from basic copying of patents into world-class, automated manufacturing compliance where data integrity is sacrosanct.